INVA8001

Sharma et al., June 2026

INVA8001, a Novel and Highly Selective Chymase Inhibitor, Ameliorates Liver Inflammation, Fibrosis, and Hyperplasia in Mdr2 Knockout Mice
Learn more

SUBSCRIBE TO OUR E-MAILS

Don't miss new updates on your email
Invea-Therapeutics-Inflammatory-Therapies_Logo_May-2023_White-PowerBy

Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders

Visit Us

2614 Boston Post Road, Suite #33B
Guilford, CT 06437, USA

  • +1 (203) 643-8060
  • info@inveatx.com
Linkedin
Quick Links
Invea-Therapeutics-Inflammatory-Therapies_Logo_May-2023_White-PowerBy

Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders

Visit Us

2614 Boston Post Road Suite #33AR
Guilford, CT 06437, USA

  • +1 (203) 643-8060
  • info@inveatx.com
Linkedin
Quick Links

© 2024 Invea Therapeutics, Inc. All rights reserved | Privacy Policy | Terms of Use